Blend Labs, Inc. (NYSE:BLND) Insider Oxana Tkach Sells 18,324 Shares of Stock

Blend Labs, Inc. (NYSE:BLNDGet Free Report) insider Oxana Tkach sold 18,324 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $5.18, for a total transaction of $94,918.32. Following the completion of the sale, the insider now owns 88,677 shares in the company, valued at $459,346.86. This represents a 17.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Oxana Tkach also recently made the following trade(s):

  • On Monday, September 23rd, Oxana Tkach sold 4,303 shares of Blend Labs stock. The shares were sold at an average price of $3.98, for a total transaction of $17,125.94.

Blend Labs Stock Down 1.9 %

Shares of BLND stock opened at $5.18 on Wednesday. Blend Labs, Inc. has a 12-month low of $1.21 and a 12-month high of $5.40. The company has a market capitalization of $1.33 billion, a P/E ratio of -15.23 and a beta of 1.16. The firm has a 50-day moving average price of $3.96 and a 200 day moving average price of $3.34.

Analyst Ratings Changes

Several analysts have recently weighed in on BLND shares. Canaccord Genuity Group lifted their target price on shares of Blend Labs from $4.75 to $5.75 and gave the company a “buy” rating in a research report on Thursday, November 7th. Wells Fargo & Company lifted their target price on shares of Blend Labs from $3.50 to $4.50 and gave the company an “overweight” rating in a research report on Thursday, November 7th. Canaccord Genuity Group upgraded shares of Blend Labs from a “hold” rating to a “buy” rating and lifted their target price for the company from $3.00 to $4.75 in a research report on Monday, August 12th. UBS Group lifted their price target on shares of Blend Labs from $3.00 to $4.00 and gave the company a “neutral” rating in a report on Wednesday, October 23rd. Finally, The Goldman Sachs Group lifted their price target on shares of Blend Labs from $3.40 to $3.90 and gave the company a “buy” rating in a report on Thursday, November 7th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $4.46.

Check Out Our Latest Stock Report on Blend Labs

Hedge Funds Weigh In On Blend Labs

A number of institutional investors have recently modified their holdings of BLND. Dark Forest Capital Management LP bought a new stake in shares of Blend Labs during the second quarter worth approximately $31,000. Xponance Inc. bought a new stake in shares of Blend Labs during the second quarter worth approximately $35,000. Caxton Associates LP acquired a new position in Blend Labs during the first quarter valued at approximately $60,000. Virtu Financial LLC acquired a new position in Blend Labs during the third quarter valued at approximately $63,000. Finally, SG Americas Securities LLC acquired a new position in Blend Labs during the first quarter valued at approximately $70,000. 52.56% of the stock is owned by institutional investors.

About Blend Labs

(Get Free Report)

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

Recommended Stories

Insider Buying and Selling by Quarter for Blend Labs (NYSE:BLND)

Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.